Virtual Library
Start Your Search
- Virtual Library Home
- IASLC Library
- Explore Event
-
WCLC 2022
2022 World Conference on Lung Cancer
As an IASLC member, you can enjoy complimentary access to the presentations from the World Conference on Lung Cancer 2022. If you participated in the conference, kindly utilize the code "WCLC2022ACCESSFULL" to enter the virtual meeting and access the recordings.
Presentation Date(s):- August 6 - 9, 2022
- Total Presentations: 2015
-
+
EP08.01 - Metastatic Non-small Cell Lung Cancer - Immunotherapy
- Type: E-Poster
- Track: Metastatic Non-small Cell Lung Cancer - Immunotherapy
- Presentations: 108
- Coordinates: 8/07/2022, 09:45 - 18:00, Exhibit Hall - Hall B
-
+
EP08.01-029 - NIVIPI-BRAIN, A Phase II Study of Nivolumab plus Ipilimumab Combined with Chemotherapy for Patients with NSCLC and Synchronous Brain Metastases
Author(s): Ernest Nadal- Abstract
Loading... -
+
EP08.01-065 - Prevalence of Non-driver Mutations and Characterization of Patients with Advanced or Metastatic Non-small Cell Lung Cancer
Author(s): Mariano Provencio- Abstract
Loading...
-
+
EP08.02 - Metastatic Non-small Cell Lung Cancer - Molecular Targeted Treatments
- Type: E-Poster
- Track: Metastatic Non-small Cell Lung Cancer - Molecular Targeted Treatments
- Presentations: 171
- Coordinates: 8/07/2022, 09:45 - 18:00, Exhibit Hall - Hall B
-
+
EP08.02-131 - Alectinib after Crizotinib Failure in Patients with Advanced ALK‑Positive NSCLC: Results from the Spanish Early Access Program
Author(s): Reyes Bernabé-Caro- Abstract
Loading...
-
+
OA02 - From Locally Advanced to Unresectable NSCLC: Improvement of Multimodality Treatment
- Type: Oral
- Track: Locally Advanced Non-small Cell Lung Cancer
- Presentations: 9
- Moderators:Isabelle Opitz
- Coordinates: 8/07/2022, 12:00 - 13:00, Hall C7
-
+
OA02.03 - Tumor Bulk-RNA Seq Identifies Patients at High Risk of Progression in Non-complete Pathological Responders from NADIM Trial
12:02 - 12:12 | Author(s): Marta Casarrubios
- Abstract
Loading...
-
+
P1.09 - Global Health, Health Services Research, and Health Economics - Support to Patients and Staff
- Type: Regular Poster
- Track: Global Health, Health Services Research, and Health Economics - Support to Patients and Staff
- Presentations: 3
- Coordinates: 8/07/2022, 17:00 - 19:00, Exhibit Hall - Hall B
-
+
P1.09-03 - Multidisciplinary Thoracic Tumors Board Survey in Spain
Author(s): Bartomeu Massutí- Abstract
Loading...
-
+
PL03 - Plenary 3: Presidential Symposium - Top Rated Abstracts (Live Streamed Session)
- Type: Plenary
- Track: N/A
- Presentations: 17
- Moderators:Heather Wakelee
- Coordinates: 8/08/2022, 08:30 - 10:20, Hall C1
-
+
PL03.12 - Progression Free Survival and Overall Survival in NADIM II Study
Author(s): Mariano Provencio- Abstract
Loading...
-
+
MA06 - Resectable and Unresectable Locally Advanced Lung Cancer
- Type: Mini Oral
- Track: Locally Advanced Non-small Cell Lung Cancer
- Presentations: 13
- Moderators:Saulius Cicenas
- Coordinates: 8/08/2022, 12:15 - 13:15, Lehar 1
-
+
MA06.03 - Pre-treatment ctDNA Levels Significantly Predicts of OS and PFS in NADIM II Trial
12:17 - 12:22 | Author(s): Atocha Romero
- Abstract
Loading...
-
+
ES25 - Clinical Issues with Immunotherapy in Non-small Cell Lung Cancer
- Type: Education Session
- Track: Metastatic Non-small Cell Lung Cancer - Immunotherapy
- Presentations: 9
- Moderators:Martin Reck
- Coordinates: 8/08/2022, 16:00 - 17:00, Hall C1
-
+
ES25.04 - First-Line Choice in PD-L1 Negative Patients
16:14 - 16:26 | Author(s): Delvys Rodriguez-Abreu
- Abstract
Loading...
-
+
OA12 - Novel and Combination Strategies for SCLC
- Type: Oral
- Track: Small Cell Lung Cancer and Neuro-Endocrine Tumors
- Presentations: 10
- Moderators:Alessandra Curioni-Fontecedro
- Coordinates: 8/08/2022, 16:00 - 17:00, Hall C8
-
+
OA12.06 - First-Line Pembrolizumab or Placebo Combined With Etoposide and Platinum for ES-SCLC: KEYNOTE-604 Long-Term Follow-Up Results
16:32 - 16:42 | Author(s): Charles M Rudin
- Abstract
Loading...
-
+
OA15 - Patient Selection in Advanced NSCLC Immunotherapy
- Type: Oral
- Track: Metastatic Non-small Cell Lung Cancer - Immunotherapy
- Presentations: 10
- Moderators:Pilar Garrido
- Coordinates: 8/09/2022, 14:30 - 15:30, Hall C7
-
+
OA15.06 - Pooled Analysis of Outcomes With Second-Course Pembrolizumab Across 5 Phase 3 Studies of Non-Small-Cell Lung Cancer
15:02 - 15:12 | Author(s): Delvys Rodriguez-Abreu
- Abstract
Loading...
